DE1139236B - Process for the production of therapeutically valuable stitosterol preparations - Google Patents
Process for the production of therapeutically valuable stitosterol preparationsInfo
- Publication number
- DE1139236B DE1139236B DEB65853A DEB0065853A DE1139236B DE 1139236 B DE1139236 B DE 1139236B DE B65853 A DEB65853 A DE B65853A DE B0065853 A DEB0065853 A DE B0065853A DE 1139236 B DE1139236 B DE 1139236B
- Authority
- DE
- Germany
- Prior art keywords
- sitosterol
- preparations
- production
- therapeutically valuable
- stitosterol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Description
DEUTSCHESGERMAN
PATENTAMTPATENT OFFICE
B 65853 IVa /30 hB 65853 IVa / 30 h
BEKANNTMACHUNG DER ANMELDUNG UNDAUSGABE DER AUSLEGESCHRIFT:NOTICE THE REGISTRATION AND ISSUE OF EDITORIAL:
8. FEBRUAR 1962FEBRUARY 8, 1962
8. NOVEMBER 1962NOVEMBER 8, 1962
Gegenstand der Patentanmeldung B 62020 IVa/30h (deutsche Auslegeschrift 1 131 845) ist ein Verfahren zur Herstellung therapeutisch wertvoller Sitosterin-Zubereitungen, welches dadurch gekennzeichnet ist, daß man handelsübliches, grobdispers vorliegendes Sitosterin in Gegenwart ausreichender Mengen von Füllstoffen auf eine Teilchengröße unterhalb 30 Mikron mahlt und das Mahlgut in Anwesenheit von Gelatine in Wasser suspendiert, worauf man aus den so erhaltenen Suspensionen gegebenenfalls das Wasser ganz oder teilweise entfernt.The subject of patent application B 62020 IVa / 30h (German Auslegeschrift 1 131 845) is a method for the production of therapeutically valuable sitosterol preparations, which is characterized by that one commercially available, coarsely present sitosterol in the presence of sufficient amounts of Mills fillers to a particle size below 30 microns and the millbase in the presence of Gelatin suspended in water, whereupon from the suspensions thus obtained, if necessary, the Part or all of the water removed.
Wie in der Hauptpatentanmeldung näher ausgeführt ist, besitzt Sitosterin nur dann eine gute antisklerotische Wirksamkeit, wenn es dem Organismus in sehr feiner Verteilung zugeführt wird. Der Verabreichung von Sitosterin des erforderlichen Zerteilungsgrades stehen jedoch das hohe spezifische Volumen eines solchen Produkts sowie seine außerordentlich starke Hydrophobie im Wege. Weitere Schwierigkeiten ergeben sich beim Vermählen des Handelsproduktes sowie bei der Verdichtung des hohen Volumens, welche (wie ebenfalls in der Hauptpatentanmeldung näher erläutert ist) nur durch Suspendierung in Wasser bewirkt werden kann. Besonders lästig ist die Thixotropie, die wäßrige Suspensionen bzw. Pasten von feinzerteiltem Sitosterin zeigen.As detailed in the main patent application, sitosterol only has a good anti-sclerotic effect Effectiveness when it is supplied to the organism in very fine distribution. The administration of sitosterol of the required degree of division, however, stand the high specific volume of a such a product as well as its extremely strong hydrophobicity in the way. More difficulties arise when grinding the commercial product and when compacting the high volume, which (as is also explained in more detail in the main patent application) only by suspension in Water can be effected. The thixotropy is particularly annoying, the aqueous suspensions or Show pastes of finely divided sitosterol.
Nach dem Verfahren der Hauptpatentanmeldung wird durch Zugabe von Gelatine die Thixotropie der Sitosterin-Suspensionen aufgehoben. Da Gelatine üblicherweise als Verdickungsmittel verwendet wird, war dieser Befund sehr überraschend, zumal es sich herausstellte, daß Alginate und verschiedene Cellulosederivate (Carboxymethylcellulose, Äthylcellulose) keinen solchen Effekt aufweisen. Es wurde nun gefunden, daß man an Stelle von Gelatine auch Methylcellulose zur Aufhebung der Thixotropie von Sitosterin-Suspensionen verwenden kann; Gemische dieser beiden Stoffe sind ebenfalls brauchbar. Die hiermit hergestellten Zubereitungen besitzen im Vergleich zu den nur gelatinehaltigen Präparaten eine erhöhte Stabilität.According to the process of the main patent application, the thixotropy of the Sitosterol suspensions lifted. Since gelatin is commonly used as a thickener, This finding was very surprising, especially since it turned out that alginates and various Cellulose derivatives (carboxymethyl cellulose, ethyl cellulose) do not have such an effect. It was now found that instead of gelatin, methyl cellulose can also be used to neutralize the thixotropy of Can use sitosterol suspensions; Mixtures of these two substances can also be used. the Preparations produced with it have compared to the preparations containing only gelatin increased stability.
Zur Herstellung der neuen Sitosterin-Zubereitungen wird — ebenso wie beim Verfahren der
Hauptpatentanmeldung — handelsübliches bzw. sonstwie vorgegebenes grobdisperses Sitosterin in
Gegenwart von geeigneten Füllstoffen, z. B. kristallinen Zuckern, wie Rohrzucker oder Milchzucker,
in Mahlvorrichtungen ausreichender Zerteilungskraft auf eine Teilchengröße unterhalb
30 Mikron, vorzugsweise etwa 5 bis 10 Mikron, zerkleinert. Hierfür eignen sich besonders gut die
sogenannten Strahlmühlen. Dann wird das Mahl-Verfahren zur Herstellung therapeutisch
wertvoller Sitosterin-ZubereitungenTo produce the new sitosterol preparations - as in the process of the main patent application - commercially available or otherwise specified coarsely dispersed sitosterol in the presence of suitable fillers, eg. B. crystalline sugars such as cane sugar or milk sugar, comminuted in grinding devices of sufficient dividing power to a particle size below 30 microns, preferably about 5 to 10 microns. The so-called jet mills are particularly suitable for this. Then the grinding method of preparation becomes therapeutic
valuable sitosterol preparations
Zusatz zur Patentanmeldung B 62020 IVa/30 h
(Auslegeschrift 1 131 845)Addition to patent application B 62020 IVa / 30 h
(Interpretation document 1 131 845)
Anmelder:Applicant:
C. F. Boehringer & Soehne G. m. b. H.,
Mannheim-WaldhofCF Boehringer & Soehne G. mb H.,
Mannheim-Waldhof
Dr. Peter Rieckmann, Mannheim-Waldhof,
ist als Erfinder genannt wordenDr. Peter Rieckmann, Mannheim-Waldhof,
has been named as the inventor
gut — in Abänderung des Verfahrens der Haupt-Patentanmeldung — in Gegenwart von Methylcellulose angeteigt, wobei man (je nach Wassermenge) dünnflüssige Suspensionen bis Pasten erhält, welche keine nennenswerte Thixotropie mehr zeigen. Im allgemeinen genügt ein Zusatz von etwa 0,1 bis 2% Methylcellulose, bezogen auf die eingesetzte Sitosterinmenge. Bei der Anteigung können außerdem etwa gewünschte Geschmackskorrigentien, Konservierungsmittel od. dgl. zugesetzt werden.good - in modification of the procedure of the main patent application - made into a paste in the presence of methylcellulose, whereby (depending on the amount of water) Thin suspensions to pastes are obtained which no longer show any noteworthy thixotropy. In general, an addition of about 0.1 to 2% methyl cellulose, based on the amount used, is sufficient Amount of sitosterol. In addition, any desired flavor corrections and preservatives can be added to the pasting or the like. Be added.
Besonders vorteilhafte Darreichungsformen der erfindungsgemäß herzustellenden Sitosterin-Suspensionen bzw. -Pasten erhält man durch Lyophilisierung derselben.Particularly advantageous forms of administration of the sitosterol suspensions to be produced according to the invention or pastes are obtained by lyophilizing the same.
40 kg handelsübliches Sitosterin werden (gegebenenfalls nach ausreichender Vorzerkleinerung) mit 10,0 kg kristallinem Rohrzucker gemischt. Die Mischung wird auf einer sogenannten Strahlmühle bis auf eine Teilchengröße von etwa 10 Mikron gemahlen. Das Mahlgut wird mit einer (warm zubereiteten und wieder erkalteten) Lösung aus 0,5 kg Methylcellulose, 12,5 kg Zucker, 100 g Sorbinsäure und 300 g einer l%igen alkoholischen Vanillinlösung in 36,6 kg Wasser zu einer homogenen Masse verrührt.40 kg of commercially available sitosterol are added (if necessary after sufficient pre-shredding) 10.0 kg of crystalline cane sugar mixed. The mixture is made on a so-called jet mill ground to a particle size of about 10 microns. The grist is heated with a (warm prepared and cooled again) solution of 0.5 kg methyl cellulose, 12.5 kg sugar, 100 g sorbic acid and 300 g of a 1% alcoholic vanillin solution in 36.6 kg of water to form a homogeneous mass stirred.
Das erhaltene Produkt kann direkt als »Sitosterin-Saft« verabreicht werden, wobei im Falle der Abfüllung derselben in Flaschen zur Vermeidung einer späteren Verklebung der Flaschenverschlüsse bei der Herstellung des Saftes zweckmäßig etwa 10% der obengenannten Menge Wasser durch Glycerin ersetzt sind.The product obtained can be administered directly as "sitosterol juice", although in the case of bottling same in bottles to avoid later sticking of the bottle closures in the In the preparation of the juice, it is advisable to replace about 10% of the above-mentioned amount of water with glycerine are.
209 680/317209 680/317
Durch Lyophilisiening des Saftes erhält man ein für manche Fälle der therapeutischen Anwendung besonders gut geeignetes »Sitosterin-Granulat«.By lyophilizing the juice one obtains a therapeutic application in some cases particularly suitable »sitosterol granules«.
Claims (1)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL276700D NL276700A (en) | 1961-04-05 | ||
DEB62020A DE1131845B (en) | 1961-04-05 | 1961-04-05 | Process for the production of therapeutically valuable sitosterol preparations |
DEB65853A DE1139236B (en) | 1961-04-05 | 1962-02-08 | Process for the production of therapeutically valuable stitosterol preparations |
GB804162A GB934686A (en) | 1961-04-05 | 1962-03-01 | Therapeutic preparations containing sitosterol |
LU41386D LU41386A1 (en) | 1961-04-05 | 1962-03-15 | |
BR13716962A BR6237169D0 (en) | 1961-04-05 | 1962-03-15 | IMPROVEMENT IN PROCESS FOR THE PREPARATION OF FINALLY DIVIDED SITOSTERIN COMPOSITIONS |
NL276700A NL142069B (en) | 1961-04-05 | 1962-04-03 | PROCESS FOR THE PREPARATION OF THERAPEUTICALLY VALUABLE SITOSTEROL PREPARATIONS. |
BE615975A BE615975A (en) | 1961-04-05 | 1962-04-04 | Therapeutic compositions containing sitosterin and their preparation |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEB62020A DE1131845B (en) | 1961-04-05 | 1961-04-05 | Process for the production of therapeutically valuable sitosterol preparations |
DEB65853A DE1139236B (en) | 1961-04-05 | 1962-02-08 | Process for the production of therapeutically valuable stitosterol preparations |
Publications (1)
Publication Number | Publication Date |
---|---|
DE1139236B true DE1139236B (en) | 1962-11-08 |
Family
ID=25965908
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DEB62020A Pending DE1131845B (en) | 1961-04-05 | 1961-04-05 | Process for the production of therapeutically valuable sitosterol preparations |
DEB65853A Pending DE1139236B (en) | 1961-04-05 | 1962-02-08 | Process for the production of therapeutically valuable stitosterol preparations |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DEB62020A Pending DE1131845B (en) | 1961-04-05 | 1961-04-05 | Process for the production of therapeutically valuable sitosterol preparations |
Country Status (6)
Country | Link |
---|---|
BE (1) | BE615975A (en) |
BR (1) | BR6237169D0 (en) |
DE (2) | DE1131845B (en) |
GB (1) | GB934686A (en) |
LU (1) | LU41386A1 (en) |
NL (2) | NL142069B (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6041612A (en) * | 1983-08-13 | 1985-03-05 | Mihama Hisaharu | Preventive and remedy for thrombosis |
DE3829643A1 (en) * | 1988-09-01 | 1990-03-15 | Roecar Holdings Nv | PHYTO AND ZOOSTEROLS AND THEIR DERIVATIVES WITH IMPROVED WATER SOLUBILITY |
FI105887B (en) * | 1996-09-27 | 2000-10-31 | Suomen Sokeri Oy | Products containing plant sterol for use in food and therapeutic applications, process for their preparation and their use |
FI108110B (en) * | 1997-06-13 | 2001-11-30 | Danisco Finland Oy | A premixture useful for the food and animal nutrition industry, a process for its preparation and its use |
US6423363B1 (en) † | 1997-08-22 | 2002-07-23 | Lipton, Division Of Conopco, Inc. | Aqueous dispersion |
EP1146798A2 (en) * | 1999-01-15 | 2001-10-24 | Nutrahealth Ltd. (UK) | Modified food products and beverages, and additives for food and beverages |
DE60004479T2 (en) * | 1999-02-03 | 2004-06-24 | Forbes Medi-Tech Inc., Vancouver | METHOD FOR PRODUCING PHYTOSTEROL OR PHYTOSTANOL MICROPARTICLES |
AU2003251484B2 (en) | 2002-06-12 | 2009-06-04 | The Coca-Cola Company | Beverages containing plant sterols |
US7732000B2 (en) | 2002-06-20 | 2010-06-08 | General Mills, Inc. | Food intermediate having sequestered phytosteryl esters in a polysaccharide matrix |
DE102005008445A1 (en) * | 2005-02-24 | 2006-08-31 | Cognis Ip Management Gmbh | Sugary sterol solid dispersions |
US11285108B1 (en) * | 2021-03-09 | 2022-03-29 | Naturalis S.A. | Phytosterols for the prevention or treatment of non-alcoholic steatohepatitis |
-
0
- NL NL276700D patent/NL276700A/xx unknown
-
1961
- 1961-04-05 DE DEB62020A patent/DE1131845B/en active Pending
-
1962
- 1962-02-08 DE DEB65853A patent/DE1139236B/en active Pending
- 1962-03-01 GB GB804162A patent/GB934686A/en not_active Expired
- 1962-03-15 LU LU41386D patent/LU41386A1/xx unknown
- 1962-03-15 BR BR13716962A patent/BR6237169D0/en unknown
- 1962-04-03 NL NL276700A patent/NL142069B/en not_active IP Right Cessation
- 1962-04-04 BE BE615975A patent/BE615975A/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE1131845B (en) | 1962-06-20 |
BE615975A (en) | 1962-10-04 |
NL276700A (en) | |
BR6237169D0 (en) | 1973-05-24 |
GB934686A (en) | 1963-08-21 |
LU41386A1 (en) | 1962-05-15 |
NL142069B (en) | 1974-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0126379B1 (en) | Two-phase formulation | |
DE69110592T2 (en) | Pharmaceutical preparation with improved taste, containing porous particles, and its method of manufacture. | |
EP0060933B1 (en) | Process for the preparation of a composition for promoting the growth of hair | |
DE1139236B (en) | Process for the production of therapeutically valuable stitosterol preparations | |
EP0062749A1 (en) | Method for the production of precipitated silicas | |
DE2238540A1 (en) | N- (D-6-METHYL-8-ISOERGOLIN-I-YL) -N ', N'-DIAETHYLURA AND ITS SALT AND PRODUCTION OF THE- OR. THE SAME AND THESE PHARMACEUTICAL PRODUCTS, INCLUDING | |
EP0553658B2 (en) | Pharmaceutically active composition from Tanacetum partenium, process of extraction and medicinal composition | |
EP0343678B1 (en) | Process for carefully preparing plant extracts | |
DE4038385C2 (en) | Sitosterol and its glycosides with improved bioavailability | |
DE2206285A1 (en) | TRANSPARENT DENTAL CARE AND DENTAL CLEANING PRODUCTS | |
DE69207777T2 (en) | BODY CARE | |
DE2623682C3 (en) | Process for the preparation of an aqueous dispersion containing sorbic acid as fine particles in a high concentration | |
DE60013231T2 (en) | PROCESS FOR OBTAINING SAFRAN EXTRACTS | |
DE3526669C2 (en) | ||
DE958243C (en) | Process for the production of anhydrous dicalcium phosphate with a cleaning force between 2 and 15, preferably between 10 and 13 | |
DE2750841A1 (en) | METHOD OF PREPARING A PROTEIN PREPARATION FROM SAFFLORO SEEDS AND PREPARED PROTEIN PREPARATION | |
EP0126999B1 (en) | Process for making spherical crystalline 5-hydroxytetracycline hydrochloride (oxytetracycline hydrochloride) | |
DE3523991A1 (en) | METHOD FOR PRODUCING AN ELIXIR | |
DE1543481C (en) | Zearalenol derivative and process for its preparation | |
Jacob et al. | Über Bürzeldrüsensekrete von Finkenvögeln: Vergleichende Untersuchung der Bürzellipide vom Grünfink (Carduelis chloris), Gimpel (Pyrrhula pyrrhula) und Hänfling (Carduelis cannabina)/The Uropygial Gland Fats of the Greenfinch, Bullfinch and the Linnet | |
DE1543481B1 (en) | Zearalenol derivative and process for its preparation | |
DE2405218C3 (en) | Antiperspirant product and process for its manufacture | |
DE948153C (en) | Process for the preparation of the higher melting isomer of 2-AEthylcrotonylurea | |
DE3718661C2 (en) | Aqueous methylene bisthiocyanate dispersion | |
DE702218C (en) | Process for the decomposition of wet grains |